New Breast Cancer Drug Kills Mouse Tumors in a Single Dose
Breast cancer treatment has come a long way, yet for many patients, the journey remains grueling. Surgery, followed by years of hormone therapy, is the standard approach for estrogen receptor-positive (ER+) breast cancer. While practical, this regimen brings harsh side effects and the looming risk of recurrence. A new experimental drug could change everything. In …